Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The TRIUMPH study was designed to build on the existing literature by studying the efficacy
of tofacitinib in hospitalized patients with acute severe ulcerative colitis. This trial will
provide evidence for a possible new indication for the use of tofacitinib.
Phase:
Phase 2
Details
Lead Sponsor:
McMaster University
Collaborators:
McGill University University of Alberta University of British Columbia University of Manitoba